5-Ethyl-N,N-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-sulfonamide

Catalog No.: 
ACWIOD682
CAS No.: 
1244027-83-5
Molecular Formula: 
C13H24BN3O4S
Molecular Weight: 
329.23
5-Ethyl-N,N-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-sulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$1114.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Ethyl-N,N-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-sulfonamide
IUPAC Name5-ethyl-N,N-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-sulfonamide
Molecular FormulaC13H24BN3O4S
Molecular Weight329.23
SMILESO=S(N1N=CC(B2OC(C)(C)C(C)(C)O2)=C1CC)(N(C)C)=O
InChI KeyAXPKXFBRSPIUIP-UHFFFAOYSA-N
Synonym5-ethyl-N,N-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-sulfonamide
CAS No.1244027-83-5

Synthetic Route by SureRoute

1. ACWIOD682 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWIOD682 route product structure diagram
    ACWIOD6821244027-83-5
Inquiry

2. ACWIOD682 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWIOD682 route product structure diagram
    ACWIOD6821244027-83-5
Inquiry

3. ACWIOD682 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWIOD682 route product structure diagram
    ACWIOD6821244027-83-5
Inquiry

Comments (0)